Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.535
-0.095 (-5.83%)
Nov 21, 2024, 1:32 PM EST - Market open
Context Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 7.06 | 7.29 | 7.79 | 3.63 | 0.93 | 2.97 |
| Research & Development | 25.48 | 17.78 | 7.09 | 3.81 | 1.64 | 2.41 |
| Operating Expenses | 32.55 | 25.07 | 14.88 | 7.44 | 2.57 | 5.38 |
| Operating Income | -32.55 | -25.07 | -14.88 | -7.44 | -2.57 | -5.38 |
| Interest Expense | - | - | - | -0.06 | -0.66 | -1.1 |
| Interest & Investment Income | 2.46 | 1.16 | 0.55 | - | - | - |
| Other Non Operating Income (Expenses) | -0.07 | -0.06 | -0 | 0.01 | 9.88 | 0.09 |
| EBT Excluding Unusual Items | -30.15 | -23.96 | -14.34 | -7.49 | 6.64 | -6.38 |
| Other Unusual Items | - | - | - | 0.13 | - | - |
| Pretax Income | -30.15 | -23.96 | -14.84 | -10.46 | 6.64 | -6.38 |
| Net Income | -30.15 | -23.96 | -14.84 | -10.46 | 6.64 | -6.38 |
| Preferred Dividends & Other Adjustments | - | - | - | - | 5.57 | - |
| Net Income to Common | -30.15 | -23.96 | -14.84 | -10.46 | 1.07 | -6.38 |
| Shares Outstanding (Basic) | 42 | 16 | 16 | 3 | 0 | - |
| Shares Outstanding (Diluted) | 42 | 16 | 16 | 3 | 2 | - |
| Shares Change (YoY) | 162.59% | - | 463.44% | 37.90% | - | - |
| EPS (Basic) | -0.72 | -1.50 | -0.93 | -3.69 | 3.07 | - |
| EPS (Diluted) | -0.72 | -1.50 | -0.93 | -3.69 | -3.96 | - |
| Free Cash Flow | -16.88 | -21.05 | -13.59 | -8.8 | -1.03 | -2.84 |
| Free Cash Flow Per Share | -0.40 | -1.32 | -0.85 | -3.11 | -0.50 | - |
| EBITDA | -32.54 | -25.06 | -14.87 | - | - | - |
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | - | - | - |
| EBIT | -32.55 | -25.07 | -14.88 | -7.44 | -2.57 | -5.38 |
Source: S&P Capital IQ. Standard template.
Financial Sources.